Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Down 45.8% in May
MarketBeat
Avalo Therapeutics, Inc. (NASDAQ:AVTX - Get Free Report) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 46,900 shares, a decrease of 45.8% from the May 15th total of 86,500 shares. Based on an average daily volume of 88,200 shares, the days-to-cover ratio is presently 0.5 days. Approximately 0.5% of the shares of the stock are sold short.
NASDAQ:AVTX
